Interruption of poliovirus transmission in Ghana: molecular epidemiology of wild-type 1 poliovirus isolated from 1995 to 2008

J Infect Dis. 2012 Oct 1;206(7):1111-20. doi: 10.1093/infdis/jis474. Epub 2012 Jul 24.

Abstract

Described in detail is the molecular epidemiology of wild-type 1 poliovirus circulation in Ghana between 1995-2008, following the implementation of a surveillance system for cases of acute flaccid paralysis and poliovirus infection. Molecular phylogenetic analysis combined with a detailed evaluation of epidemiological indicators revealed that the geographical and temporal circulation of wild-type poliovirus in Ghana was determined by the quality of the implementation of global eradication strategies. The transmission of "indigenous" wild-type 1 poliovirus was eliminated in 1999. However, a drastic reduction in national immunization campaigns resulted in the importation in 2003 and 2008 of wild-type 1 poliovirus from neighboring countries. Both outbreaks were promptly interrupted following resumption of immunization activities. The results detailed here provide scientific evidence that supports the feasibility of polio eradication in Central West Africa, one of the remaining endemic areas for the disease, provided that comprehensive immunization campaigns and sensitive surveillance systems are in place.

Publication types

  • Historical Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Disease Eradication
  • Disease Outbreaks
  • Endemic Diseases / history
  • Feces / virology
  • Ghana / epidemiology
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Mass Vaccination
  • Molecular Epidemiology
  • Molecular Typing
  • Paraplegia / epidemiology
  • Paraplegia / history
  • Paraplegia / virology
  • Phylogeny
  • Poliomyelitis / epidemiology
  • Poliomyelitis / prevention & control
  • Poliomyelitis / transmission*
  • Poliomyelitis / virology
  • Poliovirus / genetics*
  • Poliovirus / isolation & purification
  • Poliovirus Vaccine, Inactivated / administration & dosage
  • Recombination, Genetic
  • Sequence Analysis, RNA

Substances

  • Poliovirus Vaccine, Inactivated